“…For example, in critical illness, intravenous insulin is preferable to subcutaneous insulin, and the frequent measurement of whole-blood glucose instead of finger-stick glucose helps to avoid errors. 55,68 And although researchers were unable to prospectively identify patients with long ICU stays, 59 severely septic patients have long ICU stays (generally 7.5-16.6 days), [1][2][3][4] and individual ICUs might observe enough stays of more than 2 days in their patient population to justify intensive insulin for this subgroup. And finally, although no conclusive evidence mandates a specific approach to hyperglycemia outside the ICU, the ICU data provide a physiologic rationale for cautious but tight control of glucose in more moderately ill patients.…”